ImageneBio, Inc.
IMABiological Products, (No Diagnostic Substances) · SIC 2836 · CIK 0001835579
Revenue FY2025
$1.0M
Net Income
$(45.0M)
EPS (Basic)
$-9.64
Net Margin
-5668.6%
ROE
-34.1%
Total Equity
$133.0M
Shares Out
11M
ImageneBio, Inc. — Biological Products, (No Diagnostic Substances). Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2020–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 2 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
OrbiMed Advisors
OrbiMed Advisors
$5.4M
0.0%
+140.2%
Adage Capital Management
Adage Capital Management
$0.4M
0.0%
—
Insider Transactions
Reading stored insider transactions…